Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Extension Study
NCT01704378Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Apr 2001
- Primary completion
- Mar 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
A Phase 4 trial of Insulin aspart + insulin aspart protamine in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Apr 2001; status: completed.
02
Drugs
Insulin aspart + insulin aspart protamine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01704378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01704378.